Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial

This publication has 18 references indexed in Scilit:

• Preventive effects of transdermal 17β-estradiol on osteoporotic changes after surgical menopause: A two-year placebo-controlled trial
  American Journal of Obstetrics and Gynecology, 1993
• Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy
  BJOG: An International Journal of Obstetrics and Gynaecology, 1992
• The Effects of Different Formulations of Oral Contraceptive Agents on Lipid and Carbohydrate Metabolism
  New England Journal of Medicine, 1990
• THE EFFECTS OF NAFARELIN AND DANAZOL ON VERTEBRAL TRABECULAR BONE MASS IN PATIENTS WITH ENDOMETRIOSIS
  Clinical Endocrinology, 1990
• Performance evaluation of a dual-energy X-ray bone densitometer
  Calcified Tissue International, 1989
• A Comparison of the Skeletal Effects of Goserelin and Danazol in Premenopausal Women with Endometriosis
  Hormone Research, 1989
• Limited hormonal responsiveness of ectopic endometrium: Histologic correlation with intrauterine endometrium
  Human Pathology, 1988
• Steroidal regulation of endometriosis tissue: lack of induction of 17β-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol
  Fertility and Sterility, 1985
• Ultrastructural comparison of endometriotic implants and eutopic endometrium
  American Journal of Obstetrics and Gynecology, 1984
• Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness
  American Journal of Obstetrics and Gynecology, 1981